D21.6 Billable / specific Benign neoplasm of connective and other soft tissue of trunk, unspecified

ICD-10-CM D21.6 identifies “Benign neoplasm of connective and other soft tissue of trunk, unspecified” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 2: Neoplasms

Code-level instructions

Inclusion terms1

Benign neoplasm of connective and other soft tissue of back NOS

Inherited instructions

Chapters 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

D21 · Other benign neoplasms of connective and other soft tissue

Includes11
  • benign neoplasm of blood vessel
  • benign neoplasm of bursa
  • benign neoplasm of cartilage
  • benign neoplasm of fascia
  • benign neoplasm of fat
  • benign neoplasm of ligament, except uterine
  • benign neoplasm of lymphatic channel
  • benign neoplasm of muscle
  • benign neoplasm of synovia
  • benign neoplasm of tendon (sheath)
  • benign stromal tumors
Excludes 113
  • benign neoplasm of articular cartilage (D16.-)
  • benign neoplasm of cartilage of larynx (D14.1)
  • benign neoplasm of cartilage of nose (D14.0)
  • benign neoplasm of connective tissue of breast (D24.-)
  • benign neoplasm of peripheral nerves and autonomic nervous system (D36.1-)
  • benign neoplasm of peritoneum (D20.1)
  • benign neoplasm of retroperitoneum (D20.0)
  • benign neoplasm of uterine ligament, any (D28.2)
  • benign neoplasm of vascular tissue (D18.-)
  • hemangioma (D18.0-)
  • lipomatous neoplasm (D17.-)
  • lymphangioma (D18.1)
  • uterine leiomyoma (D25.-)
Official index references
History

Code history

Latest recorded change · FY2021

ChangedUnchanged
FY2021

Effective from

  • Code-level rules changed

Benign neoplasm of connective and other soft tissue of trunk, unspecified

Billable diagnosis code

CDC/NCHS · FY2021

All editions (19)

All editionsEffective fromCode history
FY20162015-10-01First observed
FY20172016-10-01No tabular change
FY20182017-10-01No tabular change
FY20192018-10-01No tabular change
FY20202019-10-01Code-level rules changed
FY2020 · April2020-04-01No tabular change
FY20212020-10-01Code-level rules changed
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01No tabular change
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change
Historical ICD-9 mappings · 2018

Historical mapping only; not an automatic code substitution.

  • 215.7

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.